Literature DB >> 24011637

Genetic diversity and linkage disequilibrium in the chemokine receptor CCR2-CCR5 region among individuals and populations.

Collene Lawhorn1, Vadim Yuferov, Matthew Randesi, Ann Ho, Susan Morgello, Mary Jeanne Kreek, Orna Levran.   

Abstract

BACKGROUND: Chemokine receptors CCR2 and CCR5 play a key role in immune and inflammatory responses and have been associated with several diseases, including AIDS. In order to comprehend health disparities it is important to understand the nature of genetic variation in specific genes of interest in different populations. Current studies of the CCR2 and CCR5 receptor genes are primarily focused on the CCR5-Δ32, and CCR2-V64I SNPs.
METHODS: Sanger sequencing was used to sequence the regions containing 16 SNPs in the adjacent CCR2 and CCR5 genes (including CCR5-Δ32, and CCR2-V64I) in 249 subjects of African, European and Hispanic ancestry. Linkage disequilibrium (LD) and haplotypes were determined using Haploview.
RESULTS: The data revealed large differences in allele frequencies of several SNPs and LD patterns among the ethnic groups, including SNPs that were restricted to Africans or Europeans. Seven known CCR5 haplotypes and six novel CCR2 haplotypes were identified. A rare case of an HIV+ subject with the CCR5-Δ32/Δ32 was identified.
CONCLUSIONS: These data demonstrate a LD between CCR2 and CCR5 at several loci and provide new information about CCR2 that contributes to our understanding of its population-specific genetic variability. The data indicate that in addition to CCR5-Δ32 and CCR2-V64I, other SNPs and haplotypes may be important genetic determinants of disease and should be investigated.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CCR2; CCR5; Chemokine receptors; Ethnicity; Health disparities

Mesh:

Substances:

Year:  2013        PMID: 24011637      PMCID: PMC3806048          DOI: 10.1016/j.cyto.2013.08.008

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  30 in total

Review 1.  The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS.

Authors:  S J O'Brien; J P Moore
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

2.  Concordance of CCR5 genotypes that influence cell-mediated immunity and HIV-1 disease progression rates.

Authors:  Gabriel Catano; Zoya A Chykarenko; Andrea Mangano; J-M Anaya; Weijing He; Alison Smith; Rosa Bologna; Luisa Sen; Robert A Clark; Andrew Lloyd; Ludmila Shostakovich-Koretskaya; Sunil K Ahuja
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

3.  Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.

Authors:  R Liu; W A Paxton; S Choe; D Ceradini; S R Martin; R Horuk; M E MacDonald; H Stuhlmann; R A Koup; N R Landau
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

4.  Allelic frequencies of host genetic variants influencing susceptibility to HIV-1 infection and disease in South African populations.

Authors:  C Williamson; S A Loubser; B Brice; G Joubert; T Smit; R Thomas; M Visagie; M Cooper; E van der Ryst
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

Review 5.  Chemokine receptors and their role in inflammation and infectious diseases.

Authors:  C Murdoch; A Finn
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

6.  Chemokine receptor gene polymorphisms and risk of human T lymphotropic virus type I infection in Jamaica.

Authors:  Michie Hisada; Renu B Lal; Silvina Masciotra; Donna L Rudolph; Maureen P Martin; Mary Carrington; Rainford J Wilks; Angela Manns
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

7.  Global distribution of the CCR2-64I/CCR5-59653T HIV-1 disease-protective haplotype.

Authors:  J J Martinson; L Hong; R Karanicolas; J P Moore; L G Kostrikis
Journal:  AIDS       Date:  2000-03-31       Impact factor: 4.177

8.  Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Authors:  M Samson; F Libert; B J Doranz; J Rucker; C Liesnard; C M Farber; S Saragosti; C Lapoumeroulie; J Cognaux; C Forceille; G Muyldermans; C Verhofstede; G Burtonboy; M Georges; T Imai; S Rana; Y Yi; R J Smyth; R G Collman; R W Doms; G Vassart; M Parmentier
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

9.  The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease.

Authors:  S Morgello; B B Gelman; P B Kozlowski; H V Vinters; E Masliah; M Cornford; W Cavert; C Marra; I Grant; E J Singer
Journal:  Neuropathol Appl Neurobiol       Date:  2001-08       Impact factor: 8.090

10.  Expression of ephrin receptors and ligands in postmortem brains of HIV-infected subjects with and without cognitive impairment.

Authors:  Vadim Yuferov; Ann Ho; Susan Morgello; Yaning Yang; Jurg Ott; Mary Jeanne Kreek
Journal:  J Neuroimmune Pharmacol       Date:  2013-01-12       Impact factor: 4.147

View more
  4 in total

1.  CCR2 and CCR5 genes polymorphisms in women with cervical lesions from Pernambuco, Northeast Region of Brazil: a case-control study.

Authors:  Erinaldo Ubirajara Damasceno dos Santos; Géssica Dayane Cordeiro de Lima; Micheline de Lucena Oliveira; Sandra de Andrade Heráclio; Hildson Dornelas Angelo da Silva; Sergio Crovella; Maria de Mascena Diniz Maia; Paulo Roberto Eleutério de Souza
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-03-15       Impact factor: 2.743

2.  Chemokines in Gestational Diabetes Mellitus.

Authors:  Hongying Liu; Aizhong Liu; Atipatsa C Kaminga; Judy McDonald; Shi Wu Wen; Xiongfeng Pan
Journal:  Front Immunol       Date:  2022-02-08       Impact factor: 7.561

Review 3.  Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders.

Authors:  Laura Fantuzzi; Maria Tagliamonte; Maria Cristina Gauzzi; Lucia Lopalco
Journal:  Cell Mol Life Sci       Date:  2019-08-03       Impact factor: 9.261

4.  Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19.

Authors:  Sueva Cantalupo; Vito Alessandro Lasorsa; Roberta Russo; Immacolata Andolfo; Giuseppe D'Alterio; Barbara Eleni Rosato; Giulia Frisso; Pasquale Abete; Gian Marco Cassese; Giuseppe Servillo; Ivan Gentile; Carmelo Piscopo; Matteo Della Monica; Giuseppe Fiorentino; Giuseppe Russo; Pellegrino Cerino; Carlo Buonerba; Biancamaria Pierri; Massimo Zollo; Achille Iolascon; Mario Capasso
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.